The severity of BF.7 variant of coronavirus in India may not be as serious as it is currently prevailing in China as Indian have already developed 'herd immunity' a top official of CSIR- Centre for......
Allaying fears about BF.7 variant of coronavirus, a prominent scientist on Friday said it is a sub-variant of Omicron strain and that India need not worry too much about its severity on the......
'If the government does its job of vaccinating all the population with the booster dose, and also monitoring the virus, and we do our job of wearing a mask and avoiding crowded places, we will be......
Kerala, Andhra Pradesh and Chandigarh reported their first Omicron case on Sunday, while Maharashtra and Karnataka each recorded one more case of the COVID-19 variant, taking the tally in the......
The COVID-19 vaccines administered in India will be effective in the country's fight against the new variant of the virus Omicron and will provide a shield to vaccinated citizens of the country,......
The annual award includes a pure gold medal, a citation and a prize purse worth $ 100,000 or its equivalent in the Indian rupees. IMAGE: Addressing an event organised to announce the winners of......
'In certain sectors we want to become catalysts, in others we want to encourage.' S D Shibulal discusses Axilor Ventures with Ayan Pramanik and Raghu Krishnan. IMAGE: Along with other......
The company has been developing donor-derived stem cell platforms for regenerative medicine and drug discovery applications. Image: Subhadra Dravida, founder, Transcell Biologics. ......
The biotech company's revenues had fallen to as low as Rs 50 cr after it lost a WHO contract, but now it hopes to reach Rs 700 cr in two years. It's sheer luck that made you succeed in an otherwise......
Indian scientists who wrote to the PM last week are not entirely rejecting GMOs but instead asking for caution and further testing to establish their safety, writes Rajni Bakshi. When dignitaries......